期刊文献+

常见的患者偏好随机对照试验方法介绍与评价 被引量:2

The introduction and evaluation of patient preference randomized controlled trials
下载PDF
导出
摘要 为了解决传统的随机对照试验在临床实际操作过程中面临的患者的偏好、伦理和依从性等,研究者们提出了患者偏好随机对照试验。介绍几种常用的患者偏好设计方案:患者偏好二阶段设计(Wennberg设计、Rücker设计)、全面队列设计(Brewin设计和Olschewski设计)、预随机设计和Korn设计等,并评价各个设计方案的优缺点,以便研究人员和临床医生根据研究目的、疾病特点等特征选择合适的方案。 In order to solve the problems of randomized controlled trials, such as patient preferences, ethics and compliance, researchers have proposed patient preference randomized controlled trials. This study mainly introduces some designs: patient preference two-stage trial design (Wennberg design, Racker design), comprehensive cohort design (Brewin design and Olschewski design), prerandomized design and Korn design. This study also evaluated the advantages and disadvantages of these designs, so that researchers and clinical doctors could select the appropriate designs according to the research purpose and the characteristics of the disease.
出处 《天津中医药大学学报》 CAS 2016年第1期64-68,共5页 Journal of Tianjin University of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81403296) 广州中医药大学"薪火计划"(XH20140105) 广州中医药大学"青年英才"资助项目(QNYC20140101) 公益性行业科研专项项目(201207005)
关键词 患者偏好随机对照试验 方法 评价 patient preferences randomized controlled trials method evaluation
  • 相关文献

参考文献20

  • 1Kaptchuk TJ. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf[J]. J Clin Epidemiol,2001,54(6):541-549.
  • 2Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance[J]. BMJ,2008,337:a1655.
  • 3陈新林,李先涛,胡镜清,莫传伟,徐谦,刘保延.复杂干预的设计和评价方法[J].辽宁中医药大学学报,2013,15(4):81-83. 被引量:8
  • 4Halpern SD. Evaluating preference effects in partially unblinded, randomized clinical trials[J]. J Clin Epidemiol,2003, 56(2):109-115.
  • 5Mcpherson K, Britton AR, Wennberg JE. Are randomized controlled trials controlled Patient preferences and unblind trials[J]. J R Soc Med,1997,90(12):652-656.
  • 6Preference Collaborative Review Group. Patients' preferences within randomised trials: systematic review and patient level meta-analysis[J]. BMJ,2008,337:a1864.
  • 7King M, Nazareth I, Lampe F, et al. Impact of participant and physician intervention preferences on randomized trials: a systematic review[J]. JAMA,2005,293(9):1089-1099.
  • 8Wennberg JE, Barry MJ, Fowler FJ, et al. Outcomes research, PORTs, and health care reform[J]. Ann N Y Acad Sci,1993, 703:52-62.
  • 9King M, Nazareth I, Lampe F, et al. Conceptual framework and systematic review of the effects of participants\' and professionals\' preferences in randomised controlled trials[J]. Health Technol Assess,2005,9(35):1-186.
  • 10Noel PH, Larme AC, Meyer J, et al. Patient choice in diabetes education curriculum. Nutritional versus standard content for type 2 diabetes[J]. Diabetes Care,1998,21(6):896-901.

二级参考文献21

  • 1MRC.A framework for the development and evaluation of RCTs for complex interventions to improve health [ R ] .London: Medical Research Council, 2000 : 18.
  • 2Craig P, Dieppe P, Macintyre S, et al.Developing and evaluating complex interventions: new guidance [ J ] .BMJ,2008,337: a1655.
  • 3Dowding DW, Cheyne HL, Hundley V, et al.Complex interventions in midwifery care: Reflections on the design and evaluation of an algorithm for the diagnosis of labour [ J ] .Midwif- ery,2011,27 ( 5 ): 654-659.
  • 4Brown CA, Lilford RJ.The stepped wedge trial design: a systematic review [ J ] .BMC Med Res Methodol, 2006,6: 54.
  • 5Hussey MA, Hughes JP.Design and analysis of stepped wedge cluster randomized trials [ J ] .Contemp Clin Trials,2007 (28): 182-191.
  • 6Preference Collaborative Review Group.Patients' preferences within randomised trials: systematic review and patient level meta-analysis [ J ] .BMJ, 2008,337 : a 1864.
  • 7King M, Nazareth I, Lampe F, et al.Impact of participants and physician intervention preferences on randomised trials: a systematic review [ J ] .JAMA, 2005,293: 1089-1099.
  • 8Torgerson D J, Klaber-Moffett J, Russell IT.Patient preferences in randomised trials : threat or opportunily? [ J ] .J Health Serv Res Policy, 1996,1 : 194-197.
  • 9Guyattg, Sackett D, Taylor DW, et al.determining optimal therapy-randomized trials in individual patients [ J ] .N Engl J Med, 1986,314: 889-892.
  • 10Irwig L, Glasziou P, March L.Ethics of n-of-I trials [ J ] .Lancet, 1995,345 : 469.

共引文献7

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部